ArticleFrontiers in microbiology2021

A Therapeutic Strategy to Combat HIV-1 Latently Infected Cells With a Combination of Latency-Reversing Agents Containing DAG-Lactone PKC Activators.

Kouki Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.